Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2023-01-09 00:00:00 ET · period of report 2023-01-05 · accession 0001415889-23-000692 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-09 | 2023-01-05 | PTCT | Boulding Mark Elliott | EVP AND CLO | A - Grant | $0.00 | +17.0K | 78.1K | +28% | $0 |
| D | 2023-01-09 | 2023-01-05 | PTCT | Boulding Mark Elliott | EVP AND CLO | A - Grant | $0.00 | +36.2K | 36.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-05 | A | A | 17,000 | $0.00 | 78,110 | D | — | — | (F1) Restricted stock units granted on January 5, 2023 that vest in four equal installments over four years, commencing on January 5, 2024. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-01-05 | A | A | 36,250 | $0.00 | 36,250 | D | $39.42 · — to 2033-01-04 | 36,250 Common Stock | (F2) This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024. |